Hydrocodone Classification Change

PBIRx®

Intelligent Solutions in Pharmacy Benefits

612 Wheelers Farms Road, Milford, CT 06461

(888) 797-2479

 

For safety reasons, the U.S. Drug Enforcement Administration (DEA) has reclassified medications containing hydrocodone to a Schedule CII narcotic. In the past, medications that contained hydrocodone were considered controlled substances, but the classification was not as high. Effective October 6, the new classification means that a doctor can no longer include refills for these medications on prescriptions.

So why is the DEA making this change? These changes are designed to minimize the misuse of these medications, while still making sure that patients with severe pain have reasonable access to the medications they need.

And what does this mean for you? The following are a few important things to consider as of October 6, 2014:

• Any remaining refills on current hydrocodone products will no longer be valid. You will need to see your doctor each time you need a refill for a written prescription. 
• Your doctor will NOT be allowed to call in or fax hydrocodone prescriptions.
• In some states, nurses or physician assistants will no longer be able to prescribe hydrocodone medications.

Maxor sent out letters explaining this change to members who have had these meds filled at mail order within the last 90 days.

Please note, however, that there may be some member disruption. Most pharmacists and doctors are aware of the new classification of hydrocodone and will be prepared for the change. As noted in the communication from Maxor, there has been ample notification of the impending change.

This is an excellent class of drugs for treating pain; however, it is a highly abused drug class that is often diverted from its intended purposes and used for drug abuse. That is why we view it as a positive change to reduce unwarranted abuse of this class of drugs.

For more information, please contact PBIRx at (888) 797-2479!